Lillie J - Search Results

1

Genetic analysis of early- versus late-stage ovarian tumors.

Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC Jr, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. Shridhar V, et al. Among authors: lillie j. Cancer Res. 2001 Aug 1;61(15):5895-904. Cancer Res. 2001. PMID: 11479231

2

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.

Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, Bast RC, Stec J, Iartchouk N, Smith DI, Ross JS, Hoersch S, Shridhar V, Lillie J, Kaufmann SH, Clark EA, Damokosh AI. Hartmann LC, et al. Among authors: lillie j. Clin Cancer Res. 2005 Mar 15;11(6):2149-55. doi: 10.1158/1078-0432.CCR-04-1673. Clin Cancer Res. 2005. PMID: 15788660

3

Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.

Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI. Shridhar V, et al. Among authors: lillie j. Cancer Res. 2002 Jan 1;62(1):262-70. Cancer Res. 2002. PMID: 11782386

4

Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer.

Denison SR, Becker NA, Ferber MJ, Phillips LA, Kalli KR, Lee J, Lillie J, Smith DI, Shridhar V. Denison SR, et al. Among authors: lillie j. Genes Chromosomes Cancer. 2002 Aug;34(4):406-15. doi: 10.1002/gcc.10084. Genes Chromosomes Cancer. 2002. PMID: 12112530

5

Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.

Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Miller DV, et al. Among authors: lillie j. Mod Pathol. 2004 Jul;17(7):756-64. doi: 10.1038/modpathol.3800114. Mod Pathol. 2004. PMID: 15073601 Free article.

6

Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast RC Jr, Gershenson DM, Schmandt R. Shvartsman HS, et al. Among authors: lillie j. Gynecol Oncol. 2003 Jul;90(1):44-50. doi: 10.1016/s0090-8258(03)00257-9. Gynecol Oncol. 2003. PMID: 12821340

7

Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.

Lillie JW, O'Keefe M, Valinski H, Hamlin HA Jr, Varban ML, Kaddurah-Daouk R. Lillie JW, et al. Cancer Res. 1993 Jul 1;53(13):3172-8. Cancer Res. 1993. PMID: 8319226

8

Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.

Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. Healy AM, et al. Among authors: lillie j. Circulation. 2006 May 16;113(19):2278-84. doi: 10.1161/CIRCULATIONAHA.105.607333. Epub 2006 May 8. Circulation. 2006. PMID: 16682612

9

Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses.

Lillie JW, Smee DF, Huffman JH, Hansen LJ, Sidwell RW, Kaddurah-Daouk R. Lillie JW, et al. Antiviral Res. 1994 Apr;23(3-4):203-18. doi: 10.1016/0166-3542(94)90018-3. Antiviral Res. 1994. PMID: 8042860

10

Specific targeting of tumor cells by the creatine analog cyclocreatine.

Martin K, Winslow E, Okeefe M, Khandekar V, Hamlin A, Lillie J, Kaddurahdaouk R. Martin K, et al. Among authors: lillie j. Int J Oncol. 1996 Nov;9(5):993-9. doi: 10.3892/ijo.9.5.993. Int J Oncol. 1996. PMID: 21541606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page